MedPath

Exevir Bio BV

Exevir Bio BV logo
🇧🇪Belgium
Ownership
Holding
Established
2020-01-01
Employees
1
Market Cap
-
Website
http://www.exevir.com

Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19

Phase 1
Terminated
Conditions
Covid19
Interventions
First Posted Date
2021-05-12
Last Posted Date
2022-04-15
Lead Sponsor
ExeVir Bio BV
Target Recruit Count
27
Registration Number
NCT04884295
Locations
🇲🇩

Investigative site, Chisinau, Moldova, Republic of

🇮🇹

Investigative Site, Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath